B-cell maturation antigen (BCMA) in multiple myeloma: the new frontier of targeted therapies
Outcomes of patients with multiple myeloma (MM) who become refractory to standard therapies are particularly poor and novel agents are greatly needed to improve outcomes in such patients. B-cell maturation antigen (BCMA) has become an important therapeutic target in MM with three modalities of treat...
Na minha lista:
| Principais autores: | , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publishing
2021-01-01
|
| coleção: | Therapeutic Advances in Hematology |
| Acesso em linha: | https://doi.org/10.1177/2040620721989585 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|